Robert Hidalgo

Robert has extensive experience in the medical device, biotech and pharmaceutical industries. He oversaw the development and launch of over 10 different products while at Boston Scientific and Medtronic. As a Global Project Manager for Genentech, he focused on biologics for the treatment of HER2+ breast cancer, including Perjeta, Herceptin and Kadcyla. Robert holds a graduate degree in Industrial Engineering from the University of Costa Rica and an MBA from Harvard Business School.

‍